Skip to main content

Altered Growth Phenotype of a Burkitt’s Lymphoma Line Following the Introduction and Stable Expression of the EBNA 2A Gene

  • Conference paper
Mechanisms in B-Cell Neoplasia 1988

Summary

Using recombinant retrovirus-mediated transfer, the coding region for the Epstein-Barr virus-encoded EBNA 2A gene was selectively introduced and stably expressed in the Louckes Burkitt lymphoma cell line. Transfected cells displayed the following altered growth characteristics when compared with the parental line: (i) maintenance of proliferation at reduced serum concentrations, (ii) improved seeding efficiency, (iii) production of a unique growth-enhancing factor, (iv) increased sensitivity to the unique factor. These growth-related changes were accompanied by the appearance of large amounts of soluble CD23 fragments in medium conditioned by Louckes cells expressing EBNA 2A. Tumor-promoting phorbol esters were found to induce similar phenotypic change in the Louckes parental line as seen on the introduction of the EBNA 2A gene. Possible mechanisms by which EBNA 2A provides a growth advantage to B lymphoma cells are discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Cairns J A, Flores-Romo L, Millsum M J, Guy G R, Ledbetter J A, Gillis S, Gordon J (1988) Soluble CD23 is released by B lymphocytes cycling in response to interleukin 4 and anti-Bp50 (CDw40) Eur. J. Immunol. (In press).

    Google Scholar 

  • Dambaugh T, Wang F, Hennessy K, Woodland E, Rickinson A, Kieff E (1986) Expression of Epstein-Barr virus nuclear protein 2 in rodent cells. J. Virol. 59:453–462.

    PubMed  CAS  Google Scholar 

  • Gordon J, Ley S C, Melamed M, English L S, Hughes-Jones N C (1984) Immortalised B lymphocytres produce B cell growth factor. Nature (London) 310: 145–147.

    Article  PubMed  CAS  Google Scholar 

  • Gordon J, Walker L, Guy G, Brown G, Rowe M, Rickinson A (1986) Control of human B-lymphocyte replication II. Transforming Epstein-Barr virus exploits three distinct viral signals to undermine three separate control points in B-cell growth. Immunology 58: 591–595.

    PubMed  CAS  Google Scholar 

  • Gordon J, Webb A J, Guy G R, Walker L (1987) Triggering of B lymphocytes through CD23: epitope mapping and studies using antibody derivatives indicate and allosteric mechanism of signalling. Immunology 60: 517–521.

    PubMed  CAS  Google Scholar 

  • Gregory C D, Murray R J, Edwards C J, Rickinson A B (1988) Down-regulation of cell adhesion molecules LFA-3 and ICAM-1 in Epstein-Barr virus-positive Burkitt’s lymphoma underlines tumour cell escape from virus-specific T cell surveillance. J. Exp. Med. (In press).

    Google Scholar 

  • Kamata J, Takaki K, Hinuma T, Watanabe Y (1981) Protein kinase activity associated with Epstein-Barr virus-determined nuclear antigen. Virology. 113: 512–520.

    Article  PubMed  CAS  Google Scholar 

  • Rickinson A B, Young L S, Rowe M (1987) Influence of the Epstein-Barr virus nuclear antigen EBNA 2 on the growth phenotype of virus-transformed B cells. J. Virol. 61:1310–1317.

    PubMed  CAS  Google Scholar 

  • Rowe M, Rowe D T, Gregory C D, Young L S, Farrell P J, Rupani H, Rickinson A B (1987) Differences in B cell growth phenotype reflect novel patterns of Epstein-Barr virus latent gene expression in Burkitts lymphoma cells. EMBO J. 6:2743–2751.

    PubMed  CAS  Google Scholar 

  • Swendeman S and Thorley-Lawson D A (1987) The activation antigen BLAST-2, when shed, is an autocrine BCGF for normal and transformed B cells. EMBO J. 6:1637–1642.

    PubMed  CAS  Google Scholar 

  • Wang F, Gregory C D, Rowe M, Rickinson A B, Wang D, Birkenbach M, Kikutani H, Kishimoto T, Kieff E (1987) Epstein-Barr virus nuclear antigen 2 specifically induces expression of the B-cell activation antigen CD23. Proc.Natl.Acad. Sci. USA 84:3452–3456.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1988 Springer-Verlag Berlin · Heidelberg

About this paper

Cite this paper

Gordon, J. et al. (1988). Altered Growth Phenotype of a Burkitt’s Lymphoma Line Following the Introduction and Stable Expression of the EBNA 2A Gene. In: Potter, M., Melchers, F. (eds) Mechanisms in B-Cell Neoplasia 1988. Current Topics in Microbiology and Immunology, vol 141. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-74006-0_20

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-74006-0_20

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-74008-4

  • Online ISBN: 978-3-642-74006-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics